Works by Colombo, Nicoletta


Results: 96
    1
    2

    Olaparib Addition to Maintenance Bevacizumab Therapy in Ovarian Carcinoma With BRCA-Like Genomic Aberrations.

    Published in:
    JAMA Network Open, 2024, v. 7, n. 4, p. e245552, doi. 10.1001/jamanetworkopen.2024.5552
    By:
    • Schouten, Philip C.;
    • Schmidt, Sandra;
    • Becker, Kerstin;
    • Thiele, Holger;
    • Nürnberg, Peter;
    • Richters, Lisa;
    • Ernst, Corinna;
    • Treilleux, Isabelle;
    • Medioni, Jacques;
    • Heitz, Florian;
    • Pisano, Carmela;
    • Garcia, Yolanda;
    • Petru, Edgar;
    • Hietanen, Sakari;
    • Colombo, Nicoletta;
    • Vergote, Ignace;
    • Nagao, Shoji;
    • Linn, Sabine C.;
    • Pujade-Lauraine, Eric;
    • Ray-Coquard, Isabelle
    Publication type:
    Article
    3
    4

    Effects of granulocyte-monocyte colony-stimulating factor (GM-CSF) on expression of adhesion molecules and production of cytokines in blood monocytes and ovarian cancer-associated macrophages.

    Published in:
    International Journal of Cancer, 1995, v. 60, n. 3, p. 300, doi. 10.1002/ijc.2910600304
    By:
    • Bernasconi, Sergio;
    • Matteucci, Christian;
    • Sironi, Marina;
    • Conni, Mario;
    • Colotta, Francesco;
    • Mosca, Monica;
    • Colombo, Nicoletta;
    • Bonazzi, Cristina;
    • Landoni, Fabio;
    • Corbetta, Giuseppe;
    • Mantovani, Alberto;
    • Allavena, Paola
    Publication type:
    Article
    5
    6
    7

    Comparing Outcomes Between CPX‐351 and Fludarabine‐Based Induction in Secondary Acute Myeloid Leukemia in the Real‐World Setting: The Prognostic Role of Measurable Residual Disease.

    Published in:
    Hematological Oncology, 2025, v. 43, n. 1, p. 1, doi. 10.1002/hon.70005
    By:
    • Riva, Carola;
    • Minetto, Paola;
    • Chies, Maria;
    • Vernarecci, Chiara;
    • Colombo, Nicoletta;
    • Rosellini, Sara;
    • Parodi, Alessia;
    • Tedone, Elisabetta;
    • Carminati, Enrico;
    • Nurra, Clara;
    • Puglisi, Francesco;
    • Frello, Michela;
    • Maio, Elena;
    • Ferro, Beatrice;
    • Zecchetti, Giada;
    • Fugazza, Giuseppina;
    • Nozza, Paolo;
    • Cea, Michele;
    • Lemoli, Roberto Massimo;
    • Guolo, Fabio
    Publication type:
    Article
    8

    The Total Neuropathy Score as an assessment tool for grading the course of chemotherapy-induced peripheral neurotoxicity: comparison with the National Cancer Institute-Common Toxicity Scale.

    Published in:
    Journal of the Peripheral Nervous System, 2007, v. 12, n. 3, p. 210, doi. 10.1111/j.1529-8027.2007.00141.x
    By:
    • Cavaletti, Guido;
    • Frigeni, Barbara;
    • Lanzani, Francesca;
    • Piatti, Marialuisa;
    • Rota, Stefania;
    • Briani, Chiara;
    • Zara, Gabriella;
    • Plasmati, Rosaria;
    • Pastorelli, Francesca;
    • Caraceni, Augusto;
    • Pace, Andrea;
    • Manicone, Mariagrazia;
    • Lissoni, Andrea;
    • Colombo, Nicoletta;
    • Bianchi, Giulia;
    • Zanna, Claudio
    Publication type:
    Article
    9
    10

    The WID-BC-index identifies women with primary poor prognostic breast cancer based on DNA methylation in cervical samples.

    Published in:
    Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-021-27918-w
    By:
    • Barrett, James E.;
    • Herzog, Chiara;
    • Jones, Allison;
    • Leavy, Olivia C.;
    • Evans, Iona;
    • Knapp, Susanne;
    • Reisel, Daniel;
    • Nazarenko, Tatiana;
    • Kim, Yoo-Na;
    • Franchi, Dorella;
    • Ryan, Andy;
    • Franks, Joanna;
    • Bjørge, Line;
    • Zikan, Michal;
    • Cibula, David;
    • Harbeck, Nadia;
    • Colombo, Nicoletta;
    • Dudbridge, Frank;
    • Jones, Louise;
    • Sundström, Karin
    Publication type:
    Article
    11

    Tumor microenvironment-induced FOXM1 regulates ovarian cancer stemness.

    Published in:
    Cell Death & Disease, 2024, v. 15, n. 5, p. 1, doi. 10.1038/s41419-024-06767-7
    By:
    • Battistini, Chiara;
    • Kenny, Hilary A.;
    • Zambuto, Melissa;
    • Nieddu, Valentina;
    • Melocchi, Valentina;
    • Decio, Alessandra;
    • Lo Riso, Pietro;
    • Villa, Carlo Emanuele;
    • Gatto, Alessia;
    • Ghioni, Mariacristina;
    • Porta, Francesca M.;
    • Testa, Giuseppe;
    • Giavazzi, Raffaella;
    • Colombo, Nicoletta;
    • Bianchi, Fabrizio;
    • Lengyel, Ernst;
    • Cavallaro, Ugo
    Publication type:
    Article
    12
    13

    Susceptibility to hormone-mediated cancer is reflected by different tick rates of the epithelial and general epigenetic clock.

    Published in:
    Genome Biology, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s13059-022-02603-3
    By:
    • Barrett, James E.;
    • Herzog, Chiara;
    • Kim, Yoo-Na;
    • Bartlett, Thomas E.;
    • Jones, Allison;
    • Evans, Iona;
    • Cibula, David;
    • Zikan, Michal;
    • Bjørge, Line;
    • Harbeck, Nadia;
    • Colombo, Nicoletta;
    • Howell, Sacha J.;
    • Rådestad, Angelique Flöter;
    • Gemzell-Danielsson, Kristina;
    • Widschwendter, Martin
    Publication type:
    Article
    14

    Susceptibility to hormone-mediated cancer is reflected by different tick rates of the epithelial and general epigenetic clock.

    Published in:
    Genome Biology, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s13059-022-02603-3
    By:
    • Barrett, James E.;
    • Herzog, Chiara;
    • Kim, Yoo-Na;
    • Bartlett, Thomas E.;
    • Jones, Allison;
    • Evans, Iona;
    • Cibula, David;
    • Zikan, Michal;
    • Bjørge, Line;
    • Harbeck, Nadia;
    • Colombo, Nicoletta;
    • Howell, Sacha J.;
    • Rådestad, Angelique Flöter;
    • Gemzell-Danielsson, Kristina;
    • Widschwendter, Martin
    Publication type:
    Article
    15

    Susceptibility to hormone-mediated cancer is reflected by different tick rates of the epithelial and general epigenetic clock.

    Published in:
    Genome Biology, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s13059-022-02603-3
    By:
    • Barrett, James E.;
    • Herzog, Chiara;
    • Kim, Yoo-Na;
    • Bartlett, Thomas E.;
    • Jones, Allison;
    • Evans, Iona;
    • Cibula, David;
    • Zikan, Michal;
    • Bjørge, Line;
    • Harbeck, Nadia;
    • Colombo, Nicoletta;
    • Howell, Sacha J.;
    • Rådestad, Angelique Flöter;
    • Gemzell-Danielsson, Kristina;
    • Widschwendter, Martin
    Publication type:
    Article
    16
    17
    18
    19
    20

    Early CAR<sup>−</sup> CD4<sup>+</sup> T‐lymphocytes recovery following CAR‐T cell infusion: A worse outcome in diffuse large B cell lymphoma.

    Published in:
    EJHaem, 2024, v. 5, n. 2, p. 360, doi. 10.1002/jha2.871
    By:
    • Gambella, Massimiliano;
    • Carlomagno, Simona;
    • Mangerini, Rosa;
    • Colombo, Nicoletta;
    • Parodi, Alessia;
    • Ghiggi, Chiara;
    • Giannoni, Livia;
    • Coviello, Elisa;
    • Setti, Chiara;
    • Luchetti, Silvia;
    • Serio, Alberto;
    • Laudisi, Antonella;
    • Passannante, Monica;
    • Bo, Alessandra;
    • Tedone, Elisabetta;
    • Sivori, Simona;
    • Angelucci, Emanuele;
    • Raiola, Anna Maria
    Publication type:
    Article
    21

    Concordance Between Tumor and Germline BRCA Status in High-Grade Ovarian Carcinoma Patients in the Phase III PAOLA-1/ENGOT-ov25 Trial.

    Published in:
    2021
    By:
    • Callens, Céline;
    • Vaur, Dominique;
    • Soubeyran, Isabelle;
    • Rouleau, Etienne;
    • Just, Pierre-Alexandre;
    • Guillerm, Erell;
    • Golmard, Lisa;
    • Goardon, Nicolas;
    • Sevenet, Nicolas;
    • Cabaret, Odile;
    • Harter, Philipp;
    • Gonzalez-Martin, Antonio;
    • Fujiwara, Keiichi;
    • Cecere, Sabrina Chiara;
    • Colombo, Nicoletta;
    • Marth, Christian;
    • Vergote, Ignace;
    • Maenpaa, Johanna;
    • Pujade-Lauraine, Eric;
    • Ray-Coquard, Isabelle
    Publication type:
    journal article
    22
    23
    24

    A cell-of-origin epigenetic tracer reveals clinically distinct subtypes of high-grade serous ovarian cancer.

    Published in:
    Genome Medicine, 2020, v. 12, n. 1, p. N.PAG, doi. 10.1186/s13073-020-00786-7
    By:
    • Lo Riso, Pietro;
    • Villa, Carlo Emanuele;
    • Gasparoni, Gilles;
    • Vingiani, Andrea;
    • Luongo, Raffaele;
    • Manfredi, Anna;
    • Jungmann, Annemarie;
    • Bertolotti, Alessia;
    • Borgo, Francesca;
    • Garbi, Annalisa;
    • Lupia, Michela;
    • Laise, Pasquale;
    • Das, Vivek;
    • Pruneri, Giancarlo;
    • Viale, Giuseppe;
    • Colombo, Nicoletta;
    • Manzo, Teresa;
    • Nezi, Luigi;
    • Cavallaro, Ugo;
    • Cacchiarelli, Davide
    Publication type:
    Article
    25

    Pembrolizumab plus chemotherapy in Japanese patients with persistent, recurrent or metastatic cervical cancer: Results from KEYNOTE‐826.

    Published in:
    Cancer Science, 2022, v. 113, n. 11, p. 3877, doi. 10.1111/cas.15479
    By:
    • Nishio, Shin;
    • Yonemori, Kan;
    • Usami, Tomoka;
    • Minobe, Shinichiro;
    • Yunokawa, Mayu;
    • Iwata, Takashi;
    • Okamoto, Aikou;
    • Aoki, Yoichi;
    • Itamochi, Hiroaki;
    • Takekuma, Munetaka;
    • Harano, Kenichi;
    • Yamamoto, Keiko;
    • Maruko, Takeshi;
    • Ugai, Hiroyuki;
    • Tekin, Cumhur;
    • Colombo, Nicoletta;
    • Fujiwara, Keiichi;
    • Hasegawa, Kosei;
    • Ushijima, Kimio
    Publication type:
    Article
    26
    27

    High precision radiotherapy including intensitymodulated radiation therapy and pulsed-dose-rate brachytherapy for cervical cancer: a retrospective monoinstitutional study.

    Published in:
    Journal of Contemporary Brachytherapy, 2019, v. 11, n. 6, p. 516, doi. 10.5114/jcb.2019.90478
    By:
    • Vavassori, Andrea;
    • Riva, Giulia;
    • Spoto, Ruggero;
    • Lazzari, Roberta;
    • Fodor, Cristiana;
    • Dicuonzo, Samantha;
    • Francia, Claudia Maria;
    • Augugliaro, Matteo;
    • Facondo, Giuseppe;
    • Cambria, Raffaella;
    • Comi, Stefania;
    • Cattani, Federica;
    • Botta, Francesca;
    • Bagnardi, Vincenzo;
    • Rizzo, Stefania;
    • Colombo, Nicoletta;
    • Orecchia, Roberto;
    • Jereczek-Fossa, Barbara Alicja
    Publication type:
    Article
    28

    Tumor progression and metastatic dissemination in ovarian cancer after dose‐dense or conventional paclitaxel and cisplatin plus bevacizumab.

    Published in:
    International Journal of Cancer, 2018, v. 143, n. 9, p. 2187, doi. 10.1002/ijc.31596
    By:
    • Bizzaro, Francesca;
    • Falcetta, Francesca;
    • D'Agostini, Elisa;
    • Decio, Alessandra;
    • Minoli, Lucia;
    • Erba, Eugenio;
    • Alessandro Peccatori, Fedro;
    • Scanziani, Eugenio;
    • Colombo, Nicoletta;
    • Zucchetti, Massimo;
    • Bani, Maria Rosa;
    • Ubezio, Paolo;
    • Giavazzi, Raffaella
    Publication type:
    Article
    29

    L1CAM promotes ovarian cancer stemness and tumor initiation via FGFR1/SRC/STAT3 signaling.

    Published in:
    Journal of Experimental & Clinical Cancer Research (17569966), 2021, v. 40, n. 1, p. 1, doi. 10.1186/s13046-021-02117-z
    By:
    • Giordano, Marco;
    • Decio, Alessandra;
    • Battistini, Chiara;
    • Baronio, Micol;
    • Bianchi, Fabrizio;
    • Villa, Alessandra;
    • Bertalot, Giovanni;
    • Freddi, Stefano;
    • Lupia, Michela;
    • Jodice, Maria Giovanna;
    • Ubezio, Paolo;
    • Colombo, Nicoletta;
    • Giavazzi, Raffaella;
    • Cavallaro, Ugo
    Publication type:
    Article
    30
    31
    32
    34
    35
    36
    37
    38
    39

    Development of the NOGGO GIS v1 Assay, a Comprehensive Hybrid-Capture-Based NGS Assay for Therapeutic Stratification of Homologous Repair Deficiency Driven Tumors and Clinical Validation.

    Published in:
    Cancers, 2023, v. 15, n. 13, p. 3445, doi. 10.3390/cancers15133445
    By:
    • Willing, Eva-Maria;
    • Vollbrecht, Claudia;
    • Vössing, Christine;
    • Weist, Peggy;
    • Schallenberg, Simon;
    • Herbst, Johanna M.;
    • Schatz, Stefanie;
    • Jóri, Balázs;
    • Bataillon, Guillaume;
    • Harter, Philipp;
    • Salutari, Vanda;
    • Martin, Antonio Gonzáles;
    • Vergote, Ignace;
    • Colombo, Nicoletta;
    • Roeper, Julia;
    • Berg, Tobias;
    • Berger, Regina;
    • Kah, Bettina;
    • Noettrup, Trine Jakobi;
    • Falk, Markus
    Publication type:
    Article
    40

    MRI- and Histologic-Molecular-Based Radio-Genomics Nomogram for Preoperative Assessment of Risk Classes in Endometrial Cancer.

    Published in:
    Cancers, 2022, v. 14, n. 23, p. 5881, doi. 10.3390/cancers14235881
    By:
    • Celli, Veronica;
    • Guerreri, Michele;
    • Pernazza, Angelina;
    • Cuccu, Ilaria;
    • Palaia, Innocenza;
    • Tomao, Federica;
    • Di Donato, Violante;
    • Pricolo, Paola;
    • Ercolani, Giada;
    • Ciulla, Sandra;
    • Colombo, Nicoletta;
    • Leopizzi, Martina;
    • Di Maio, Valeria;
    • Faiella, Eliodoro;
    • Santucci, Domiziana;
    • Soda, Paolo;
    • Cordelli, Ermanno;
    • Perniola, Giorgia;
    • Gui, Benedetta;
    • Rizzo, Stefania
    Publication type:
    Article
    41

    CT-Based Radiomics and Deep Learning for BRCA Mutation and Progression-Free Survival Prediction in Ovarian Cancer Using a Multicentric Dataset.

    Published in:
    Cancers, 2022, v. 14, n. 11, p. 2739, doi. 10.3390/cancers14112739
    By:
    • Avesani, Giacomo;
    • Tran, Huong Elena;
    • Cammarata, Giulio;
    • Botta, Francesca;
    • Raimondi, Sara;
    • Russo, Luca;
    • Persiani, Salvatore;
    • Bonatti, Matteo;
    • Tagliaferri, Tiziana;
    • Dolciami, Miriam;
    • Celli, Veronica;
    • Boldrini, Luca;
    • Lenkowicz, Jacopo;
    • Pricolo, Paola;
    • Tomao, Federica;
    • Rizzo, Stefania Maria Rita;
    • Colombo, Nicoletta;
    • Manganaro, Lucia;
    • Fagotti, Anna;
    • Scambia, Giovanni
    Publication type:
    Article
    42

    Biological Role of Tumor/Stromal CXCR4-CXCL12-CXCR7 in MITO16A/MaNGO-OV2 Advanced Ovarian Cancer Patients.

    Published in:
    Cancers, 2022, v. 14, n. 7, p. 1849, doi. 10.3390/cancers14071849
    By:
    • D'Alterio, Crescenzo;
    • Spina, Anna;
    • Arenare, Laura;
    • Chiodini, Paolo;
    • Napolitano, Maria;
    • Galdiero, Francesca;
    • Portella, Luigi;
    • Simeon, Vittorio;
    • Signoriello, Simona;
    • Raspagliesi, Francesco;
    • Lorusso, Domenica;
    • Pisano, Carmela;
    • Colombo, Nicoletta;
    • Zannoni, Gian Franco;
    • Losito, Nunzia Simona;
    • De Cecio, Rossella;
    • Scognamiglio, Giosuè;
    • Califano, Daniela;
    • Russo, Daniela;
    • Tuninetti, Valentina
    Publication type:
    Article
    43
    44
    45

    Evaluation of Angiogenesis-Related Genes as Prognostic Biomarkers of Bevacizumab Treated Ovarian Cancer Patients: Results from the Phase IV MITO16A/ManGO OV-2 Translational Study.

    Published in:
    Cancers, 2021, v. 13, n. 20, p. 5152, doi. 10.3390/cancers13205152
    By:
    • Califano, Daniela;
    • Gallo, Daniela;
    • Rampioni Vinciguerra, Gian Luca;
    • De Cecio, Rossella;
    • Arenare, Laura;
    • Signoriello, Simona;
    • Russo, Daniela;
    • Ferrandina, Gabriella;
    • Citron, Francesca;
    • Losito, Nunzia Simona;
    • Gargiulo, Piera;
    • Simeon, Vittorio;
    • Scambia, Giovanni;
    • Cecere, Sabrina Chiara;
    • Montella, Marco;
    • Colombo, Nicoletta;
    • Tognon, Germana;
    • Bignotti, Eliana;
    • Zannoni, Gian Franco;
    • Canzonieri, Vincenzo
    Publication type:
    Article
    46

    Fludarabine, High-Dose Cytarabine and Idarubicin-Based Induction May Overcome the Negative Prognostic Impact of FLT3 -ITD in NPM1 Mutated AML, Irrespectively of FLT3 -ITD Allelic Burden.

    Published in:
    Cancers, 2021, v. 13, n. 1, p. 34, doi. 10.3390/cancers13010034
    By:
    • Minetto, Paola;
    • Candoni, Anna;
    • Guolo, Fabio;
    • Clavio, Marino;
    • Zannier, Maria Elena;
    • Miglino, Maurizio;
    • Dubbini, Maria Vittoria;
    • Carminati, Enrico;
    • Sicuranza, Anna;
    • Ciofini, Sara;
    • Colombo, Nicoletta;
    • Pugliese, Girolamo;
    • Marcolin, Riccardo;
    • Santoni, Adele;
    • Ballerini, Filippo;
    • Lanino, Luca;
    • Cea, Michele;
    • Gobbi, Marco;
    • Bocchia, Monica;
    • Fanin, Renato
    Publication type:
    Article
    47
    48

    De novo AML patients with favourable-intermediate karyotype may benefit from the addition of low-dose gemtuzumab ozogamicin (GO) to fludarabine, Ara-C and idarubicin (FLAI): a contribution to the reopened "GO question".

    Published in:
    2013
    By:
    • Clavio, Marino;
    • Cruciani, Fabio;
    • Minetto, Paola;
    • Guolo, Fabio;
    • Ballerini, Filippo;
    • Marani, Carlo;
    • De Astis, Enrico;
    • Aquino, Sara;
    • Bergamaschi, Micaela;
    • Mitscheunig, Laura;
    • Grasso, Raffaella;
    • Colombo, Nicoletta;
    • Ghiggi, Chiara;
    • Lovera, Davide;
    • Pastori, Giordana;
    • Avenoso, Daniele;
    • Miglino, Maurizio;
    • Gobbi, Marco
    Publication type:
    journal article
    49

    De novo AML patients with favourable-intermediate karyotype may benefit from the addition of low-dose gemtuzumab ozogamicin (GO) to fludarabine, Ara-C and idarubicin (FLAI): a contribution to the reopened 'GO question'.

    Published in:
    Annals of Hematology, 2013, v. 92, n. 10, p. 1309, doi. 10.1007/s00277-013-1780-7
    By:
    • Clavio, Marino;
    • Cruciani, Fabio;
    • Minetto, Paola;
    • Guolo, Fabio;
    • Ballerini, Filippo;
    • Marani, Carlo;
    • De Astis, Enrico;
    • Aquino, Sara;
    • Bergamaschi, Micaela;
    • Mitscheunig, Laura;
    • Grasso, Raffaella;
    • Colombo, Nicoletta;
    • Ghiggi, Chiara;
    • Lovera, Davide;
    • Pastori, Giordana;
    • Avenoso, Daniele;
    • Miglino, Maurizio;
    • Gobbi, Marco
    Publication type:
    Article
    50